208 related articles for article (PubMed ID: 32680634)
1. Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
Ara R; Khatun S; Pervin S; Jahan M; Shahera U; Ferdous J; Begum SA; Fatema S; Begum M; Nazneen S; Goodman A
Gynecol Oncol; 2020 Sep; 158(3):590-596. PubMed ID: 32680634
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
Zhang Q; Dong L; Hu S; Feng R; Zhang X; Pan Q; Ma J; Zhang L; Zhao X; Sankaranarayanan R; Qiao Y; Zhao F
Int J Cancer; 2017 Sep; 141(6):1110-1119. PubMed ID: 28560716
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
4. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
5. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
[TBL] [Abstract][Full Text] [Related]
6. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
7. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.
Sellors JW; Schweizer JG; Lu PS; Liu B; Weigl BH; Cui JF; Peck RB; Lewis K; Lim J; Howard M; Mahoney CW; McAllister L; Berard-Bergery M; Bry C; Labiad YA; Li H; Liu L; Silver J; Chen W; Qiao YL
J Low Genit Tract Dis; 2011 Apr; 15(2):169-76. PubMed ID: 21478701
[TBL] [Abstract][Full Text] [Related]
8. Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
Abedin S; Paul SK; Haque N; Ahmed S; Nasreen SA; Akhter N; Haque N; Sarkar SR; Roy S; Nahar F; Ahmed MU; Switzer J; Kobayashi N; Hossain MA; Chowdhury UW
Mymensingh Med J; 2019 Jan; 28(1):31-36. PubMed ID: 30755547
[TBL] [Abstract][Full Text] [Related]
9. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
11. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
12. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
16. Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
Ferrera A; Valladares W; Cabrera Y; de la Luz Hernandez M; Darragh T; Baena A; Almonte M; Herrero R
Int J Cancer; 2019 Oct; 145(8):2042-2050. PubMed ID: 30684396
[TBL] [Abstract][Full Text] [Related]
17. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
Pierry D; Weiss G; Lack B; Chen V; Fusco J
Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
Antonishyn NA; Horsman GB; Kelln RA; Severini A
Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.
Adamopoulou M; Kalkani E; Charvalos E; Avgoustidis D; Haidopoulos D; Yapijakis C
Anticancer Res; 2009 Aug; 29(8):3401-9. PubMed ID: 19661364
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive testing by cytology, p16/Ki-67 dual-stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen-positive women.
Torres-Ibarra L; Lorincz AT; Wheeler CM; Cuzick J; Hernández-López R; Spiegelman D; León-Maldonado L; Rivera-Paredez B; Méndez-Hernández P; Lazcano-Ponce E; Salmerón J
Int J Cancer; 2021 May; 148(9):2264-2273. PubMed ID: 33252834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
